Want to see JP:6368 full AI Analyst Report?

Organo Corp. (6368) Price & Analysis

1 Followers

6368 Stock Chart & Stats

¥15140.00

-¥140.00(-0.92%)

At close: Jul 27 4:00 PM EDT

¥15140.00

-¥140.00(-0.92%)

Day’s Range― - ―

52-Week Range¥10,620.00 - ¥20,145.00

Previous CloseN/A

Volume368.30K

Average Volume (3M)305.77K

Market Cap

¥678.47B

Enterprise Value¥759.04K

Total Cash (Recent Filing)¥27.84B

Total Debt (Recent Filing)¥37.36B

Price to Earnings (P/E)24.1

Beta1.77

Next Earnings

Nov 02, 2026

EPS Estimate

166.47

Next Dividend Ex-DateN/A

Dividend Yield1.35%

Share Statistics

EPS (TTM)613.21

Shares Outstanding46,359,700

10 Day Avg. Volume290,510

30 Day Avg. Volume305,770

Financial Highlights & Ratios

PEG Ratio1.25

Price to Book (P/B)4.38

Price to Sales (P/S)3.52

P/FCF Ratio21.30

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)677.97

Revenue Forecast (FY)¥202.93B

Bulls Say, Bears Say

Bulls Say

Margin ExpansionSustained multi-year margin expansion indicates improving pricing power, product mix, or cost control. Higher margins enhance durable cash generation, support reinvestment or debt reduction, and provide a buffer through cycles—strengthening long-term earnings quality and resilience.

Consistent Revenue GrowthMulti-year top-line growth reflects stable market demand and execution across product lines. Persistent revenue expansion underpins scale economies, funds R&D/capex, and supports sustained profitability improvements, making the business less reliant on one-off gains.

Moderate Leverage And Equity GrowthA moderate debt ratio with rising equity provides balance-sheet resilience and financial flexibility. This capital structure lowers refinancing risk, allows strategic investment or M&A, and helps absorb shocks—important for long-term operational stability.

Bears Say

Cash-flow VolatilityIntermittent negative OCF/FCF shows sensitivity to working-capital swings or execution lapses. Even with recent strong FCF, volatility raises the risk that funding for capex, dividends, or debt repayment could be disrupted in downturns, requiring conservative planning.

Rising Debt In Latest YearAn uptick in borrowings, despite still-manageable leverage, increases fixed obligations and reduces slack. If revenue growth weakens or margins revert, higher debt magnifies financial risk and could constrain strategic investment or require deleveraging actions that weigh on growth.

Moderating Top-line GrowthA slowdown in revenue growth suggests maturing end markets or tougher comps. If sustained, it limits operating leverage and the ability to expand absolute profit, making the company more dependent on margin gains or inorganic growth to drive long-term EPS improvement.

Organo Corp. News

Organo Corporation Transfers Shares to Enhance Indonesian Water Treatment Venture

An announcement from Organo Corp. ( ($JP:6368) ) is now available. Organo Corporation announced its decision to transfer...

2y ago

6368

6368 FAQ

What was Organo Corp.’s price range in the past 12 months?

Organo Corp. lowest stock price was ¥10620.00 and its highest was ¥20145.00 in the past 12 months.

What is Organo Corp.’s market cap?

Organo Corp.’s market cap is ¥678.47B.

When is Organo Corp.’s upcoming earnings report date?

Organo Corp.’s upcoming earnings report date is Nov 02, 2026 which is in 77 days.

How were Organo Corp.’s earnings last quarter?

Organo Corp. released its earnings results on Aug 03, 2026. The company reported ¥74.73 earnings per share for the quarter, missing the consensus estimate of ¥134.22 by -¥59.49.

Is Organo Corp. overvalued?

According to Wall Street analysts Organo Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Organo Corp. pay dividends?

Organo Corp. pays a Semiannually dividend of ¥110 which represents an annual dividend yield of 1.35%. See more information on Organo Corp. dividends here

What is Organo Corp.’s EPS estimate?

Organo Corp.’s EPS estimate is 166.47.

How many shares outstanding does Organo Corp. have?

Organo Corp. has 46,359,700 shares outstanding.

What happened to Organo Corp.’s price movement after its last earnings report?

Organo Corp. reported an EPS of ¥74.73 in its last earnings report, missing expectations of ¥134.22. Following the earnings report the stock price went down -0.238%.

Which hedge fund is a major shareholder of Organo Corp.?

Currently, no hedge funds are holding shares in JP:6368

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Organo Corp.

Organo Corporation, a Tokyo-headquartered enterprise established in 1941 (and known as Japan Organo Co., Ltd. until its name change in 1966), is a global specialist in water treatment engineering. The company's business activities are structured into two main divisions: the Water Treatment Engineering Business Unit and the Performance Products Business Unit. It offers a comprehensive portfolio of water purification solutions, encompassing various pure water systems such as reverse osmosis (RO), regenerative (automatic and manual), electric regeneration, desktop, cabinet, electrode ionization high-purity, cartridge, and two-stage RO systems. Additionally, Organo supplies ultrapure water systems, available in desktop and cabinet models, alongside final polishing units. The company's equipment range extends to include alkaline electrolyzed water production machinery, homogenizers, electro conductivity and resistivity meters, and ion exchange filters. Beyond physical systems, Organo Corporation provides specialized chemicals for water, wastewater, and RO treatment. Its extensive selection of industrial filters covers micro, sanitary, polypropylene, and plastic housings, as well as micro, RO wound, PF cartridge, capsule, and PF carbon filters. Commercial water purifiers are also part of its product offering. Organo's expertise is applied across numerous industries: delivering ultrapure and multi-functional water production, wastewater treatment, valuable resource recovery, and organic solvent refining systems for the electronics sector; constructing water supply and sewage treatment facilities; supplying purified water, UF water, and water for injection production and supply systems, coupled with consulting services, for the pharmaceutical industry; providing critical solutions for power generation, including condensate filters, demineralizers, reactor and fuel pool cleanup, makeup water, and waste water treatment systems; and implementing sugar refining systems and associated equipment.